KIBBUTZ SHEFAYIM, Israel and VANCOUVER – Deep-learning medical imaging analytics company Zebra Medical Vision announced today it has entered a strategic collaboration with Telus Ventures to grow Zebra-Med’s presence in North America.
With FDA clearances and Health Canada approvals in hand, the company’s technology “provides a fully automated analysis of images generated in the imaging system using clinically proven AI solutions trained on hundreds of millions of patient scans to identify acute medical findings and chronic diseases,” reads the press release. The company’s AI solution has also been deployed for Covid-19 detection and disease progression tracking.
“Zebra-Med is deeply committed to enhancing care through the use of machine learning and artificial intelligence,” said Ohad Arazi, CEO. We have already impacted millions of lives globally, and we’re honoured to launch this significant collaboration with Telus Ventures, driving better care for Canadians.”
Telus Ventures is building a portfolio of investments to support Telus Health’s growth in the health technology market including digital solutions for preventive care and patient self-management. The release did not cite the level of financial commitment Telus Ventures has made in Zebra-Med.
